Sex differences in factors associated with switch between systemic agents among individuals with psoriasis: A retrospective cohort study in Quebec, Canada

• Raymond Milan, MSc,
• Jacques LeLorier, MD, PhD,
• Marie-Josée Brouillette, MD,
• Anne Holbrook, MD, PharmD, MSc,
• Ivan V. Litvinov, MD, PhD,
• Elham Rahme, PhD

Affiliations

Raymond Milan, MSc

Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada

Jacques LeLorier, MD, PhD

Faculté de Médecine, Université de Montréal, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada

Marie-Josée Brouillette, MD

Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada

Anne Holbrook, MD, PharmD, MSc

Division of Clinical Pharmacology and Toxicology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Research Institute of St. Joe's Hamilton, Saint Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada

Ivan V. Litvinov, MD, PhD

Department of Medicine, Division of Dermatology, McGill University, Montreal, Quebec, Canada

Elham Rahme, PhD

Department of Medicine, Division of Clinical Epidemiology, McGill University, Montreal, Quebec, Canada; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada; Correspondence to: Elham Rahme, PhD, Centre for Outcomes Research and Evaluation of the Research Institute of McGill University Health Centre, 5252 de Maisonneuve Boulevard W, Room 3E.12, Montreal, Quebec, H4A 3S5, Canada